[Indications for hormone therapy of male secretory sterility].
The latest therapeutic approaches to male sterility with particular reference to endocrine criteria (homologous gonadotropins, GN RH and similar, androgens, antioestrogens, thyroid hormones, etc.) and the many complex diagnostic problems still encountered are reviewed. The experiment with homologous associated gonadotropins (hMG + hCG) is particularly interesting. A significant sample (3815 dyspermic subjects identified between January 1966 and September 1981 in the Niguarda-Ca' Granda Hospital's Fertility and Sterility (Clinic) revealed an apparently normal seminal report (at least at minimum values compatible with fertility) in 74.8% of cases and a positive biological refutation (onset of pregnancy in apparently normal partners) in 17.9% of subjects judged suitable for treatment.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000728:Androgens / Q000378:metabolism / Q000627:therapeutic use*; D001971:Bromocriptine / Q000627:therapeutic use; D003348:Cortisone / Q000031:analogs & derivatives / Q000627:therapeutic use; D004965:Estrogen Antagonists / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism; D005938:Glucocorticoids / Q000627:therapeutic use; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007248:Infertility, Male / Q000628:therapy*; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D010906:Pituitary Hormone-Releasing Hormones / Q000627:therapeutic use; D011278:Pregnanes / Q000378:metabolism; D013737:Testis / Q000378:metabolism; D013963:Thyroid Hormones / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000728:Androgens; D004965:Estrogen Antagonists; D004967:Estrogens; D005938:Glucocorticoids; D006062:Gonadotropins; D007328:Insulin; D010906:Pituitary Hormone-Releasing Hormones; D011278:Pregnanes; D013963:Thyroid Hormones; D001971:Bromocriptine; D003348:Cortisone
Indirizzi di terapia ormonale della sterilità secretoria maschile.